Chronic kidney disease (CKD) is a growing, widespread, progressive, and often silent condition that represents one of the most pressing public health challenges of our time. With an estimated global prevalence of 10-15%, CKD affects around 850 million people1,2 and contributes to a wide range of complications, including kidney failure requiring dialysis or kidney transplantation, cardiovascular events, premature death and health-related reduced quality of life. The global burden of CKD is increasing with population ageing and the rise of CKD risk factors such as type 2 diabetes and hypertension.